| 词条 | Zeltia |
| 释义 |
| name = Zeltia, S.A. | logo = Zeltia-logo.jpg | logo_size = 200px | caption = | trading_name = | native_name = | native_name_lang = | romanized = | former type = | type = Sociedad Anónima | traded_as = {{BMAD|ES0184940817|ZEL}} | industry = Pharmaceutical | genre = | fate = | predecessor = | successor = | foundation = Vigo, Spain ({{Start date|1939|08|03}}) | founder = | defunct = {{end date|2015}} | location_city = Madrid | location_country = Spain | locations = | area_served = Worldwide | key_people = José Fernández Sousa-Faro (Chairman) | products = Pharmaceuticals | production = | services = | revenue = {{increase}} {{Currency|176 million|USD}} (2009) | operating_income = {{increase}} (US$46.3 million) (2009) | net_income = {{increase}} (US$40.3 million) (2009) | aum = | assets = {{increase}} US$302.9 million (2009) | equity = {{decrease}} US$59 million (2009) | owner = | num_employees = | parent = | divisions = | subsid = PharmaMar, Genómica, Sylentis, Zelnova, Xylazel | homepage = {{URL|http://www.zeltia.com/}} | footnotes = | intl = | bodystyle = }} Zeltia is a former Spanish pharmaceutical company which operated through a variety of subsidiaries in the pharmaceutical and chemical industries. As of 2007, Zeltia's research activities in the pharmaceutical area had not resulted in a marketed product. However, the company's majority shareholder and chairman are the same person, which has relieved the pressure which many CEOs have experienced to produce immediate returns. The company was taken over by its subsidiary Pharma Mar S.A. in a reverse takeover, keeping the Zeltia's Group structure. SubsidiariesDirect subsidiaries as of 2009 were: Pharma Mar, S.A.U.; Genómica, S.A.U.; Zelnova, S.A; Protección de Maderas, S.A.U; Xylazel, S.A.; Noscira, S.A.; Sylentis, S.A. Indirect subsidiaries which are direct subsidiaries of Pharma Mar as of 2009 were: Pharma Mar US; Pharma Mar AG; PharmaMar S.A.R.L.; Pharma Mar GmbH; Pharma Mar Ltd. A single indirect subsidiary is a direct subsidiary of Zelnova, that being Copyr, S.p.A. References1. ^{{cite web |url=http://www.hoovers.com/company/Zeltia_SA/rfrxfki-1.html |accessdate=7 May 2011 |title=Zeltia, S.A. |publisher=Hoover's |location=Austin, Texas, United States |at=Companies |format=database record }} 2. ^{{cite web |url=http://www.zeltia.com/analistas_inversores.cfm |title=Consolidated Financial Statements as of 31 December 2009 |date=16 April 2010 |publisher=Zeltia |accessdate=7 May 2011 }} 3. ^{{Citation |last=Clark |first=Todd D. |title=PharmaHandbook: a guide to the international pharmaceutical industry |isbn=978-0-9795443-0-9 |oclc=254331162 |type=Google Books |accessdate=7 May 2011 |edition=5 |year=2007 |page=381 |chapter=Spain |url=https://books.google.com/books?id=E-qs6BtdIUAC&lpg=PA381&dq=pharmar%20zeltia&pg=PA381#v=onepage&q=zeltia&f=false |publisher=Value of Insight Consulting |location=New Orleans, Louisiana, United States }} 4. ^{{Citation |last=Jericó |first=Pilar |title=No Fear: In Business and In Life |type=Google Books |url=https://books.google.com/books?id=XHQFHz47oGcC&lpg=PA66&dq=Zeltia&pg=PA66#v=onepage&q=Zeltia&f=false |accessdate=7 May 2011 |year=2009 |publisher=Palgrave Macmillan |location=Basingstoke, United Kingdom |isbn=978-0-230-58038-1 |oclc=636422030 |page=66 |chapter=The Price of Fear }} 5. ^{{Citation |last=Bueno |first=María José Sánchez |page=175 |isbn=978-84-9745-240-3 |oclc=434255490 |title=El proceso innovador y tecnológico: estrategias y apoyo público |type=Google Books |url=https://books.google.com/books?id=pz1vRJ-mhVEC&lpg=PA175&dq=zeltia&pg=PA175#v=onepage&q=zeltia&f=false |accessdate=7 May 2011 |year=2008 |publisher=Netbiblo |location= |language=Spanish }} FinancialHistory 6 : Pharmaceutical companies established in 1939|1939 establishments in Spain|Companies based in the Community of Madrid|Pharmaceutical companies of Spain|Chemical companies of Spain|Companies listed on the Madrid Stock Exchange |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。